Publications by authors named "Amy Gentry"

Claim this Profile
S
Seasonal variation of cytomegalovirus disease in kidney transplant recipients.
Margaret R Jorgenson, Hanna L Kleiboeker, Brad C Astor, Amy C Gentry, Christopher M Saddler

Clin Transplant· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Team Cognition As a Means to Improve Care Delivery in Critically Ill Patients With Cancer After Hematopoietic Cell Transplantation.
Nathan J McNeese, Nandita Khera, Sara E Wordingham, Noel Arring, Sharon Nyquist, Amy Gentry

J Oncol Pract· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients.
Krisstina Gowin, Prakash Thapaliya, Jan Samuelson, Claire Harrison, Deepti Radia, Amy Gentry

Haematologica· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fitness support group for organ transplant recipients: self-management, self-efficacy and health status.
Amy C S Gentry, Basia Belza, Terri Simpson

J Adv Nurs· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.
Ian Churcher, Dirk Beher, Jonathan D Best, José L Castro, Earl E Clarke, Amy Gentry

Bioorg Med Chem Lett· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
Lin Yan, Jeffrey J Hale, Christopher L Lynch, Richard Budhu, Amy Gentry

Bioorg Med Chem Lett· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity.
Christopher L Lynch, Jeffrey J Hale, Richard J Budhu, Amy L Gentry, Paul E Finke

Org Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains.
Christopher L Lynch, Christopher A Willoughby, Jeffrey J Hale, Edward J Holson, Richard J Budhu, Amy L Gentry

Bioorg Med Chem Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV.
Christopher L Lynch, Jeffrey J Hale, Richard J Budhu, Amy L Gentry, Sander G Mills

Bioorg Med Chem Lett· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines.
Christopher L Lynch, Amy L Gentry, Jeffrey J Hale, Sander G Mills, Malcolm MacCoss

Bioorg Med Chem Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis